Standout Papers

Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer 1989 2026 2001 2013 5.6k
  1. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer (1989)
    Dennis J. Slamon, William Godolphin et al. Science
  2. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update (2013)
    Antonio C. Wolff, M. Elizabeth Hammond et al. Journal of Clinical Oncology
  3. Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer (2002)
    Charles L. Vogel, Melody Cobleigh et al. Journal of Clinical Oncology
  4. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update (2018)
    Antonio C. Wolff, M. Elizabeth Hammond et al. Journal of Clinical Oncology
  5. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update (2013)
    Antonio C. Wolff, M. Elizabeth Hammond et al. Archives of Pathology & Laboratory Medicine
  6. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update (2018)
    Antonio C. Wolff, M. Elizabeth Hammond et al. Archives of Pathology & Laboratory Medicine
  7. Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk (1993)
    Malcolm C. Pike, Darcy Spicer et al. Epidemiologic Reviews
  8. Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer (2009)
    Stephen Johnston, John Pippen et al. Journal of Clinical Oncology
  9. A Big Bang model of human colorectal tumor growth (2015)
    Andrea Sottoriva, Haeyoun Kang et al. Nature Genetics
  10. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. (1997)
    Michael F. Press, Leslie Bernstein et al. Journal of Clinical Oncology
  11. Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. (1990)
    Michael F. Press, Carlos Cordon‐Cardo et al. PubMed

Immediate Impact

4 by Nobel laureates 20 from Science/Nature 110 standout
Sub-graph 1 of 18

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Telomeres: history, health, and hallmarks of aging
2021 Standout
3 intermediate papers

Works of Michael F. Press being referenced

A Big Bang model of human colorectal tumor growth
2015 Standout
Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk
1993 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Michael F. Press 19794 8487 9503 8968 222 29.9k
Edith A. Perez 20395 10865 6462 4280 395 29.5k
W. Eiermann 16006 9766 4818 5692 223 23.2k
Jorma Isola 10038 6205 9346 3903 295 22.5k
John M.S. Bartlett 10284 6777 6062 4046 306 18.4k
Robert B. Jenkins 10965 11347 12852 4953 395 34.2k
Carlos L. Arteaga 18114 6299 19578 4593 429 34.0k
Ana M. González-Angulo 14849 11118 8771 2655 278 24.6k
Ann D. Thor 9580 5736 8212 3404 209 18.1k
José Baselga 34173 9219 17049 12167 270 48.4k
Steven Shak 16418 11027 7955 5893 133 27.6k

All Works

Loading papers...

Rankless by CCL
2026